| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $98K | -18.3% | -54.2% |
| Cost of Revenue | $11K | -89.7% | -99.1% |
| R&D Expense | $8.7M | -14.8% | +71.3% |
| SG&A Expense | $5.4M | -4.1% | -30.0% |
| Operating Income | -$14.2M | +10.2% | +7.0% |
| Interest Expense | $3.9M | +2.7% | +6.7% |
| Net Income | -$30.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $36.2M | +107.5% | -10.4% |
| Accounts Receivable | $0 | -100.0% | -100.0% |
| Inventory | $459K | -9.3% | -69.9% |
| Current Assets | $44.4M | +75.9% | -7.1% |
| Total Assets | $44.8M | +73.7% | -8.4% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$43.4M | — | — |
| Capital Expenditures | $0 | — | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $50.9M | — | — |
| Free Cash Flow | -$43.4M | — | — |
| -61.1% |
| -126.5% |
| EPS (Basic) | -$2.18 | +11.0% | -581.3% |
| EPS (Diluted) | -$2.18 | +11.0% | -581.3% |
| $37.8M |
| +13.3% |
| +47.9% |
| Long-term Debt | $109.1M | +0.4% | +4.5% |
| Total Liabilities | $133.7M | +0.2% | -0.6% |
| Stockholders' Equity | -$88.9M | +17.4% | -3.8% |